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-1852 TAAGTTGATAAAGCTAATTTCTCATTTTAGCTACCATCGCTAGTAATCGTGGCAATAACT 
-1792 ACCCTAACTATAGCATTTATTGCTACCAAATAAAATTTGGCAGCTAATCATAATTTTTTG 
-1732 TCATGAATCAATAGTTATTGTAGCAATAGTTATCTCTTAGCCACAATAAATTATTTAAAA 
-1672 TAAAATATTATAGCTAAATAAATATTTTTGCTTTAAGTTCTAAAAGGTTGTGGCAATAGT 
~1612 TAAATGATATAGTCACAGATTTATTGGTATAATTGAATTATGTTGCTAATTTCTTAGTTT 
-1552 TTTGCCACGAGTTAAAAATTACCAATAGCTATAGTAACTTTTTAATCACAATAAAATATT 
—1492 TGAAAGAAAATATTGTAGCTAAATGAATATTTTTTCCTTCAAGTTATTAAAAGTTGTGGC 
1432 AATATAGGTTAAATTAGCCACATGTTTCTTGCTTTAATAGAATTTTGTAGCTAATCATTA 
1372 ACTTTTACCACGAGTTGAACTTAATATAACAACAATAACCTTTTAACCATAATAAAGCGA 
-1312 TTTAAATCAAATATTACTAAATAAATAACTTTGCTTTCAAGTTTCTATAAAATCATGGCA 
-1252 ATAGTCATTACGATAAAATGATATAACCACGAATATATTGCAACGATAAATTCTGTAACT 
r1192 AATCATTAGTTTTTGCGACGAGGTAAATTTTCCGTCACAGTAGCAATCTTCTAGGCACAT 
-ll32 TAAAAATTTGAAACAAAATTTTGTAGTCAAATAAATATTTATCTTCTTATTTTAAGAAAA 
-1072 TAAAAATAGTTAGATAATAGTTACTACTATTTGTCATGAAAATATCAATAGATACAAATT 
—1012 TAAAGTGACTATAAATTTACGAGTTTACTATACTTTAGTCGTACAGTTTGCAATAATAGT 
-952 ATTTTAACCACAATTAGTTATATGTACAAAATAACATAAGTGAATAACTTTTTTTCAATG 
-892 AGAAAATAAGAGTTGCTCAAACAATATCAAGTTACAAAAATTTAATTTTAACTGTAAAAG 
—832 TTATATTTTTCCAAAATAACATAAACTATAGTAATTATATATAGTTTGAAGTATTAATAA 
-772 AATTTAAATATGCAAAAGTTAATTTTAATAAACCATTTGTATGCCTAACTTGTAGCCTCT 
—712 AAACTATTTTATTTGCTTTATTTATCAAACTCATATTTTATTTTATTGCACCTTGTTAGT 
—652 TTTGGACGTTAATTATATATATTTGGTGTAAAATTTAAAATATATTAACATTTGTGGAGA 
~592 ATTTATGTATGCCTGGTTCTTAACTATTTTTTTTTATATAACTGGTTAGAGTAATTTCTT 
—532 ATATTTCAGTATTTATTTTTAAATAAGTCCTCATAAATTGAAGACTTTAAAAGTTTTTGT 
—47Z GTCATTCCTCTTTTTATTTAAGAAATTGAAGAATTCCGCTAAATTTCATATTTCCGCTGT 
~412 TATTTAACTGTTTATTTCCCTTGTTAATATAATTGGTAAGAAGTTTTAAAATAAAGGAGT 
-35Z TAATGATTTTCTAGGTTCATGGCTTGCCTAGCTTCTACGAGTAAGCGCCATCACGACTCC 
—292 CGAGGATAAGGAAATCCGGGTCGTAGCATTCACTCACAAAAATTACTAAAAACAAAGTTT 
-232 ACCCTTCTCCCAAAAGTAAATTTCATATTTGGCTCCACATAATGTGTTQMlGAGTCA/XG 
-172 TGAAGTACTTTTCATGACAAAAAAAAGTTGCTGAAAAATGCATATCTCATATTTTTTTTT 
~112 TAGAGAAATCQTFTCTTGCCTAAACGAAAGCC TA TAAAAGAGCATATATTGCAACAAC 
—52 AGTTTQCAGAAACTATCAAGTCAAATAATCCCCCCTTTAATTCCCTCCCAAA?QC/XGTT 
9 CTTCAACTTCTTTTCCCTTTTCCTTTTTGTGTCATTTCTCTTTTTATTTAAGAAATGGAA 
69 GAATTCCAATAGCCAAACCAAAAGATTGCCTCCAGGTCCATGG 
FIG.2 
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PLANT TRICHOME GLAND SPECIFIC 
PROMOTER SEQUENCE 
CONTINUING DATA 
This application claims the bene?t of priority to US. 
Provisional Application No. 60/191,088, ?led Mar. 22, 
2000, Which is incorporated by reference herein in its 
entirety. 
FIELD OF THE INVENTION 
The present invention relates to a trichome speci?c regu 
latory sequence such as a promoter, and heterologous con 
structs comprising the trichome speci?c regulatory sequence 
and DNAs encoding a single or multiple polypeptide of 
interest. The present invention is also related to transgenic 
expression of a polypeptide(s) of interest in the trichome. 
BACKGROUND OF THE INVENTION 
Most surfaces of most plants are said to be pubescent, or 
bearing of trichomes or hairs. The morphology of these 
structures can vary greatly With tissues and species. Indeed, 
the botanical literature is said to contain more than 300 
descriptions (uniseriate, capitate-sessile, etc.) to characteriZe 
various morphological types. These characteristics have 
often been used in plant classi?cation. Functionally, tri 
chomes may be simple hairs Which deter herbivores, guide 
the path of pollinators or affect photosynthesis, leaf 
temperature, or Water loss through increased light re?ec 
tance as in desert species. Or, they may be more specialiZed 
tissues (glandular secreting trichomes) Whose principal 
function(s) may be to produce pest- or pollinator-interactive 
chemicals Which are stored or volatiliZed at the plant sur 
face. It has been suggested that in some desert species the 
principal role of glandular secreting trichomes is to produce 
such high levels of exudate that it forms a continuous layer 
on the plant surface. This layer may increase light re?ec 
tance and thereby reduce leaf temperature. 
It is the glandular, merocrine, secreting trichome type 
Which often produce and accumulate terpenoid oils that is 
the focus of this application. Other secretory tissues occur 
ring on or in plants include salt glands, salt hairs, nectary and 
slime glands, resin ducts, and osmophores (perhaps respon 
sible for fragrances in ?oWers). Useful modi?cation might 
be genetic manipulation of an enZyme to alter the chemical 
nature of exudate for the purpose of enhancing disease 
resistance, enhancing attractiveness to pollinators, or to 
expand the metabolism of secretory cells to include synthe 
sis of compounds or intermediates not normally formed. It 
is important to point out that the potential of secreting 
trichomes to accumulate exudate is highly signi?cant in 
certain plants Where, under optimal conditions, secreted 
products can reach a level of 10 to 30% of the dry Weight of 
leaves. Glandular trichome exudates usually contain terpe 
nes and essential oils, as Well as lipophilic components not 
easily stored in large amounts Within the cell. Therefore, if 
it Were desirable to manipulate plants to produce or over 
produce a compound in this class of biochemicals, the 
secreting trichome system, Which amasses secretions outside 
of gland cells, may be more amenable to overproduction 
than one requiring intracellular storage. 
Esau, Plant Anatomy, John Wiley & Sons, N.Y. has 
de?ned trichomes as “epidermal appendages of diverse 
form, structure and functions . . . represented by protective, 
supporting, and glandular hairs, by scales, by various 
papillae, and by absorbing hairs of roots.” This de?nition 
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suggests a close relationship betWeen trichomes and root 
hairs. From this vieWpoint, aerial trichomes and subterra 
nean “trichomes” could be said to cover or nearly cover the 
surfaces of most plants. HoWever, While trichomes and root 
hairs may resemble each other in morphology, their genetic 
determinants may differ. Both trichomes and root hairs 
develop projections from protodermal cells. Glandular struc 
tures of trichomes arise from a series of anticlinal and 
periclinal divisions to form supporting auxiliary cells and 
glands as in the case of Cannabis. The appearance of glands 
atop supporting cells and the occurrence of exudate around 
gland cells has suggested to most observers that secretions 
are produced in gland cells and not by other epidermal or 
subepidermal cells. 
Hutvagner et al., Gene 188 (1997) 247—252 describes the 
potato P450 gene. The function, tissue speci?city and pro 
moter of this potato gene is not presented or discussed in the 
paper. 
Clark et al., Plant Molecular Biology 33 (1997) 875—885 
describes another P450 gene isolated Nepeta racemosa that 
hybridiZes to RNA from trichomes but not that prepared 
from leaves stripped of trichomes. This gene shoWs 36 and 
45 to 50% homology to 1—31, protein and DNA levels, 
respectively. No promoter is described in this paper. 
Wagner, Plant Physiol. 96 (1991) 675—679 provides some 
brief background on plant glanded trichomes. 
In order to produce genetically engineered polypeptides in 
trichomes there is a need to make a trichome speci?c 
regulatory sequence that alloWs for targeting of gene expres 
sion speci?cally in trichome glands. 
SUMMARY OF THE INVENTION 
It is an object of the present invention to provide an 
isolated nucleic acid molecule comprising: 
a polynucleotide set forth in SEQ ID NO:1; 
a polynucleotide Which is a variant or fragment of the 
polynucleotide set forth in SEQ ID NO:1, Wherein said 
variant or fragment has trichome speci?c transcriptional 
regulatory activity; or 
a polynucleotide sequence Which hybridiZes to the poly 
nucleotide of SEQ ID NO:1 under 5><SSC and 42° C. Wash 
conditions. 
The nucleic acid may be a polynucleotide comprising the 
sequence set forth in SEQ ID NO:1. The nucleic acid may 
further comprise a polynucleotide encoding a polypeptide. 
The polypeptide may be a disease- or pest-resistance con 
ferring protein. The polypeptide may be a pharmaceutical 
compound. The polypeptide may function to alter horticul 
tural or food plants. The polypeptide may also be a phyto 
toxic protein, or a protein highly sensitive to modi?cation 
during isolation from plant tissue homogenates. Any 
polypeptide at all can be used With the trichome speci?c 
regulatory sequence of the invention. The trichome speci?c 
regulatory sequence also encompasses a promoter sequence. 
Another object of the invention is to provide a composi 
tion comprising a polypeptide made from expression of the 
above-mentioned nucleic acid, and a trichome gland exu 
date. 
The present invention also relates to a vector comprising 
a replicable vector and the above-mentioned polynucleotide 
inserted into said vector. 
The vector may be preferably a cloning or expression 
vector, or a plant vector, preferably a binary vector. 
The present invention also relates to a cell containing the 
above-mentioned vector. Preferably, the cell is a plant cell. 
US 6,730,826 B2 
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The present invention also provides for a plant comprising 
the above-mentioned nucleic acid. 
The present invention is also related to a method for 
expressing a polypeptide comprising constructing a vector 
comprising a trichome speci?c regulatory sequence and a 
nucleic acid encoding a polypeptide, and inserting said 
vector into a plant, Wherein said polypeptide is expressed 
trichome speci?cally. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The present invention Will become more fully understood 
from the detailed description given herein beloW, and the 
accompanying draWings Which are given by Way of illus 
tration only, and thus are not limitative of the present 
invention, and Wherein; 
FIG. 1(A) shoWs dissecting microscopic vieWs and (B) 
shoWs light microscopic vieWs of TL 1068 epidermis shoW 
ing peltate glandular trichomes. Tissue “C” is epidermis 
from leaf of a non-transformed plant, and “P-GUS” is 
epidermis from a similar aged leaf of a plant expressing the 
GUS reporter gene driven by a trichome-speci?c promoter. 
Note the occurrence of GUS stain in glands only. Some 
slight blue color Was also found in the stalk cell immediately 
attached to the gland. This may represent leakage of stain 
during tissue ?xation, or movement betWeen the gland and 
the ?rst stalk cell Within the vacuolar-tubular continuum. No 
stain Was found in root, stem, or any other tissue (not 
shoWn). 
FIG. 2 (SEQ ID NO:3) shoWs a DNA sequence of 
upstream regulatory region of a tobacco trichome speci?c 
promoter (TSP), along With ?rst 111 base pair sequence of 
the ?rst exon (SEQ ID NO:1). The transcription start point, 
and the putative translation start are in bold letters and 
underlined. The putative TATA box and putative CAAT box 
sequences are italiciZed and underlined. SEQ ID NO:2 
shoWs the upstream sequence Without the protein coding 
region. 
FIG. 3 shoWs a deletion analysis of the tobacco TSP. The 
activity of full-length promoter (—1852) Was set at 100% and 
used to de?ne the relative activities of further deletions. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Abbreviations 
Abbreviations for amino acids used herein are conven 
tionally de?ned as described herein beloW unless otherWise 
indicated. 
Three-letter One-letter 
Amino Acid abbreviation symbol 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic acid Asp D 
Asparagine or aspartic acid Asx B 
Cysteine Cys C 
Diaminopropionic acid Dpr 
Glutamine Gln Q 
Glutamine acid Glu E 
Glutamine or glutamic acid Glx Z 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
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-continued 
Three-letter One-letter 
Amino Acid abbreviation symbol 
Methionine Met 
Ornithine Orn 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
Speci?cally Exempli?ed Polypeptides 
The present invention relates to DNA comprising the 
trichome speci?c regulatory sequence operably linked to 
DNA encoding any polypeptide or multiple polypeptides. 
The polypeptide can be heterologous, preferably a plant 
protein, but not necessarily limited to plant proteins. The 
polypeptide can be a variant or fragment of a polypeptide. 
Preferably, the polypeptide is expressible in the trichome 
gland. Expression and recovery from a recombinant organ 
ism can be by any convenient method. 
Substitutions, Additions and Deletions 
As possible variants of the polypeptide, the polypeptide 
may have additional individual amino acids or amino acid 
sequences inserted into the polypeptide in the middle thereof 
and/or at the N-terminal and/or C-terminal ends thereof so 
long as the polypeptide possesses the desired physical and/or 
biological characteristics. LikeWise, some of the amino acids 
or amino acid sequences may be deleted from the polypep 
tide so long as the polypeptide possesses the desired physi 
cal characteristics. Amino acid substitutions may also be 
made in the sequences so long as the polypeptide possesses 
the desired physical and biochemical characteristics. 
Sequence Identity 
TWo sequences are said to be “identical” if the sequence 
of residues is the same When aligned for maximum corre 
spondence as described beloW. The term “complementary” 
applies to nucleic acid sequences and is used herein to mean 
that the sequence is complementary to all or a portion of a 
reference polynucleotide sequence. 
Optimal alignment of sequences for comparison can be 
conducted by the local homology algorithm of Smith and 
Waterman,Aa'd. Appl. Math, 2:482 (1981), by the homology 
alignment method of Needleman and Wunsch, J. M01. Bi0l., 
48:443 (1970), by the search for similarity method of 
Pearson and Lippman, Proc. Natl. Acad. Sci. USA, 85 12444 
(1988), or the like. Computer implementations of the above 
algorithms are knoWn as part of the Genetics Computer 
Group (GCG) Wisconsin Genetics SoftWare Package (GAP, 
BESTFIT, BLASTA, FASTA and TFASTA), 575 Science 
Drive, Madison, Wis. 
“Percentage of sequence identity” is determined by com 
paring tWo optimally aligned sequences over a comparison 
WindoW, Wherein the portion of the sequence in the com 
parison WindoW may comprise additions or deletions (i.e. 
“gaps”) as compared to the reference sequence for optimal 
alignment of the tWo sequences being compared. The per 
centage identity is calculated by determining the number of 
positions at Which the identical residue occurs in both 
sequences to yield the number of matched positions, divid 
ing the number of matched positions by the total number of 
positions in the WindoW and multiplying the result by 100 to 
yield the percentage of sequence identity. Total identity is 
then determined as the average identity over all of the 
WindoWs that cover the complete query sequence. 
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Post-translational Modi?cation 
Also included Within the scope of the present invention 
are polypeptides or fragments or derivatives thereof Which 
are differentially modi?ed during or after translation, e.g., by 
glycosylation, proteolytic cleavage, phosphorylation, 
methylation, amidation of glutamic acid, aspartic acid and 
C-terminal carboxyl groups. 
Fusion Polypeptides 
The polypeptide of the present invention may be 
expressed as a fusion polypeptide or chimeric polypeptide 
With a second polypeptide as transcriptionally expressed 
from a single trichome speci?c regulatory sequence. The 
second polypeptide Will usually impart an additional prop 
erty or characteristic to the fusion polypeptide Which is not 
possessed by the polypeptide of the present invention. 
Production of Recombinant Polypeptide 
Recombinant polypeptide can be produced by a process 
Which comprises culturing the transformed cell or microor 
ganism described herein under conditions Which alloW 
expression of the polypeptide as transcriptionally regulated 
from the trichome speci?c regulatory sequence of the 
invention, optionally recovering the thus expressed polypep 
tide and optionally purifying the recovered polypeptide. In 
processes for the synthesis of the polypeptide, DNA Which 
encodes a polypeptide is ligated into a replicable 
(reproducible) vector and operably linked to the trichome 
speci?c regulatory sequence. The vector is used to transform 
host cells, and the polypeptide is recovered from the culture. 
Suitable replicable vectors are selected depending upon the 
particular host cell chosen. Suitable processes are knoWn in 
the art and are described, for example, in Sambrook et al, 
Molecular Cloning: A Laboratory Manual, 2nd Ed. c. 1989 
by Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, NY, Chapters 16, 17 and 18. 
The polypeptide produced in this manner may be different 
from natural polypeptide in that it may be free of other 
polypeptides or materials Which occur in natural polypep 
tide. The polypeptide produced by recombinant techniques 
may also contain some small amounts of contaminating 
materials from the microorganism, cells and/or fermentation 
system in Which it Was produced. Thus, the present invention 
is also directed to these neW or isolated polypeptides Which 
are produced under the transcriptional control of the tri 
chome speci?c regulatory sequence. 
Puri?cation of Recombinant Polypeptide 
Recombinant polypeptide can be recovered from cultures 
by lysing the cells to release recombinant polypeptide Which 
is present inside the cells. Initially, cell debris can be 
separated by centrifugation. The remaining debris and the 
supernatant are then repeatedly treated With solvents in 
Which the cell debris are soluble but in Which the recombi 
nant polypeptide is not soluble to thereby precipitate recom 
binant polypeptide. These procedures can be repeated and 
combined With other procedures including ?ltration, dialysis 
and/or chromatography to obtain a pure product. 
DNA and RNA 
The invention encompasses DNA including, but not lim 
ited to, that shoWn in SEQ ID NO:1. including variants and 
fragments thereof that have trichome speci?c transcriptional 
activity. The sequence of the regulator Which has actually 
been sequenced is shoWn in SEQ ID. NO:1. The present 
invention also includes genomic DNA containing or com 
prising the requisite nucleotide sequences as Well as corre 
sponding RNA and antisense sequences. 
Cloned DNA Within the scope of the invention also 
includes allelic variants of the speci?c sequences presented 
in the attached Sequence Listing. An “allelic variant” is a 
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sequence that is a variant from that of the exempli?ed 
nucleotide sequence, but represents the same chromosomal 
locus in the organism. In addition to those Which occur by 
normal genetic variation in a population and perhaps ?xed in 
the population by standard breeding methods, allelic vari 
ants can be produced by genetic engineering methods. A 
preferred allelic variant is one that is found in a naturally 
occurring organism, including a laboratory strain. Allelic 
variants are either silent or expressed. A silent allele is one 
that does not affect the phenotype of the organism. An 
expressed allele results in a detectable change in the phe 
notype of the trait represented by the locus. 
In addition to the above, the preferred upstream region of 
the trichome speci?c upstream region may be located in the 
—1273 to —1123 upstream of the putative translation initia 
tion site. Thus, in one embodiment, the present invention is 
directed to utiliZing a nucleic acid comprising a nucleic acid 
that has 75% similarity to the DNA depicted in SEQ ID 
NO:1 or has such similarity to the —1273 to —1123 region of 
SEQ ID NO: 1. More preferably, there is 80% similarity. Still 
more preferably, there is 85% similarity. Even more 
preferably, there is 90% similarity, and most preferably, 
there is 95% similarity to either the DNA depicted in SEQ 
ID NO:1 or the DNA in the region of —1273 to —1123 from 
the putative translation start site of SEQ ID NO:1. 
A nucleic acid sequence “encodes” or “codes for” a 
polypeptide if it directs the expression of the polypeptide 
referred to. The nucleic acid can be DNA or RNA. Unless 
otherWise speci?ed, a nucleic acid sequence that encodes a 
polypeptide includes both the transcribed strand and the 
mRNA or the DNA representative of the mRNA. An “anti 
sense” nucleic acid is one that is complementary to a strand 
representative of mRNA, including untranslated portions 
thereof. 
DNA Modi?cation 
The DNA is readily modi?ed by substitution, deletion or 
insertion of nucleotides, thereby resulting in novel DNA 
sequences. Methods for saturating a particular DNA 
sequence With random mutations and also for making spe 
ci?c site directed mutations are knoWn in the art; see eg 
Sambrook et al supra, Chapter 15. 
HybridiZable Variants 
The DNA molecule can comprise a nucleotide sequence 
of SEQ ID NO:1, or can comprise a nucleotide sequence of 
a nucleotide sequence that hybridiZes to a DNA molecule of 
SEQ ID NO:1 under salt and temperature conditions equiva 
lent to 5><SSC and 42° C. and that possesses the ability to 
transcriptionally regulate the expression of a gene speci? 
cally in the trichome. See Chapters 11 and 12 of Sambrook 
et al, supra. 
Recombinant DNA Constructs 
Recombinant DNA constructs comprising one or more of 
the DNA or RNA sequences described herein and an addi 
tional DNA and/or RNA sequence are also included Within 
the scope of this invention. These recombinant DNA con 
structs have sequences Which do not occur in nature or exist 
in a form that does not occur in nature or exist in association 
With other materials that do not occur in nature. The DNA 
and/or RNA sequences described herein above are “operably 
linked” With other DNA and/or RNA sequences. DNA 
regions are operably linked When they are functionally 
related to each other. For example, DNA for a presequence 
or secretory leader is operably linked to DNA for a polypep 
tide if it is expressed as a preprotein Which participates in the 
secretion of the polypeptide; a promoter is operably linked 
to a coding sequence if it controls the transcription of the 
sequence; or a ribosome binding site is operably linked to a 
US 6,730,826 B2 
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coding sequence if it is positioned so as to permit translation. 
Generally, operably linked means contiguous (or in close 
proximity to) and, in the case of secretory leaders, contigu 
ous and in reading phase. 
Vectors 
The invention is further directed to a replicable vector 
containing cDNA Which codes for a polypeptide and Which 
is capable of expressing the polypeptide under the transcrip 
tional control of a trichome speci?c regulatory sequence. 
The present invention is also directed to a vector com 
prising a replicable vector and a DNA sequence correspond 
ing to the above-described gene inserted into said vector. 
The vector may be an integrating or non-integrating vector 
and is conveniently a plasmid. 
Transformed Cells 
The invention further relates to a transformed cell or 
microorganism containing cDNA or a vector Which codes 
for the polypeptide or a fragment or variant thereof and 
Which is capable of expressing the polypeptide. 
Plant Cell Expression Systems 
Plant Vectors 
In plants, transformation vectors capable of introducing 
DNAs under the control of a trichome speci?c regulatory 
sequence are easily designed, and generally contain one or 
more DNA coding sequences of interest under the transcrip 
tional control of 5‘ and 3‘ regulatory sequences. Such vectors 
generally comprise, operatively linked in sequence in the 5‘ 
to 3‘ direction, a trichome speci?c promoter sequence that 
directs the transcription of a doWnstream heterologous struc 
tural DNA in a plant; optionally a 5‘ non-translated leader 
sequence; a nucleotide sequence that encodes a protein of 
interest; and a 3‘ non-translated region that encodes a 
polyadenylation signal Which functions in plant cells to 
cause the termination of transcription and the addition of 
polyadenylate nucleotides to the 3‘ end of the mRNA encod 
ing said protein. Plant transformation vectors also generally 
contain a selectable marker. Typical 5‘-3‘ regulatory 
sequences include a transcription initiation start site, a 
ribosome binding site, an RNA processing signal, a tran 
scription termination site, and/or a polyadenylation signal. 
Vectors for plant transformation are described (Schardl et 
al., Gene 61, 1—14, (1987); Plant Mol Biol., 25:989—994 
(1994)). Particularly useful vectors for this invention 
include, but are not limited to (pKYLX71, pPZP family, 
pKYLX71-35S2). 
Plant Transformation and Regeneration 
Avariety of different methods can be employed to intro 
duce such vectors into plant trichome, protoplasts, cells, 
callus tissue, leaf discs, meristems, etc., to generate trans 
genic plants, including Agrobacterium-mediated 
transformation, particle gun delivery, microinjection, 
electroporation, polyethylene glycol-mediated protoplast 
transformation, liposome-mediated transformation, etc. In 
general, transgenic plants comprising cells containing and 
expressing DNAs encoding various enZymes can be pro 
duced by transforming plant cells With a DNA construct as 
described above via any of the foregoing methods; selecting 
plant cells that have been transformed on a selective 
medium; regenerating plant cells that have been transformed 
to produce differentiated plants; and selecting a transformed 
plant Which expresses the enZyme-encoding nucleotide 
sequence. 
The DNAs can be introduced either in a single transfor 
mation event (all necessary DNAs present on the same 
vector), a co-transformation event (all necessary DNAs 
present on separate vectors that are introduced into plants or 
plant cells simultaneously), or by independent transforma 
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tion events (all necessary DNAs present on separate vectors 
that are introduced into plants or plant cells independently). 
Traditional breeding methods can subsequently be used to 
incorporate the entire pathWay into a single plant. Speci?c 
methods for transforming a Wide variety of dicots and 
obtaining transgenic plants are Well documented in the 
literature. 
Successful transformation and plant regeneration have 
been achieved in the monocots as folloWs: asparagus 
(Asparagus o?icinalis; Bytebier et al, Proc. Natl. Acad. Sci. 
USA, 84:5345 (1987)); barley (Hordeum vulgarae; Wan and 
Lemaux, Plant Physiol., 104:37 (1994)); maiZe (Zea mays; 
Rhodes et al, Science, 240:204 (1988); Gordon-Kamm et al, 
Plant Cell, 2:603 (1990); Fromm et al, Bio/Technology, 
8:833 (1990); KoZiel et al, Bio/Technology, 11:194 (1993)); 
oats (Avena saliva; Somers et al, Bio/Technology, 10:1589 
(1992)); orchardgrass (Dactylic glomerata; Horn et al, Plant 
Cell Rep., 7:469 (1988)); rice (Oryza saliva, including 
indica and japonica varieties; Toriyama et al, Bio/ 
Technology,6:10 (1988); Zhang et al, Plant Cell Rep., 7:379 
(1988); Luo and Wu, Plant Mol. Biol. Rep., 6:165 (1988); 
Zhang and Wu, Theor. Appl. Genet., 76:835 (1988); Chris 
tou et al, Bio/Technology,9:957 (1991)); rye (Secale cereale; 
De la Pena et al, Nature, 325:274 (1987)); sorghum 
(Sorghum bicolor; Cassas et al, Proc. Natl. Acad. Sci. USA; 
90:11212 (1993)); sugar cane (Saccharum spp.; BoWer and 
Birch, Plant J., 2:409 (1992)); tall fescue (Festuca aruna'i 
nacea; Wang et al, Bio/Technology, 10:691 (1992)); turf 
grass (Agrostis palustris; Zhang et al, Plant Cell Rep, 13:1 
(1993)); and Wheat (Triticum aestinum; Vasil et al, Bio/ 
Technology, 10:667 (1992); Weeks et al, Plant Physiol., 
102:1077 (1993); Becker et al, Plant J., 5:299 (1994)). 
Relevant Plants 
Particularly useful plants for exploiting the trichome 
gland speci?c promoter include plants and ferns of the 
genuses: Populus, Ermophilia, Lycopersicon, Nicotiana, 
Cannabis, Pharbitis, Apteria, Psychotria, Mercurialis, 
Chrysanthemum, Polypodium, Pelargonium, Polytrichiales, 
Mimulus, Chamomile, Monarda, Solanum, Achillea, 
Valeriana, Ocimum, Medicago, Aesculus, NeWcastelia, 
Plumbago, Pityrogramma, Phacelia, Avicennia, Tamarix, 
Frankenia, Limonium, Foeniculum, Thymus, Salvia, 
Kadsura, Beyeria, Humulus, Mentha, Artemisia, Nepta, 
Geraea, Pogogstemon, Majorana, Cleome, Cnicus, 
Parthenium, Ricinocarpos, Parthenium, Hymenaea, Larrea, 
Primula, Phacelia, Dryopteris, Plectranthus, Cypripedium, 
Petunia, Datura, Mucuna, Ricinus, Hypericum, Myoporum, 
Acacia, Diplopeltis, Dodonaea, Halgania, Cyanostegia, 
Prostanthera, Anthocercis, Olearia, Viscaria. This promoter 
might also be useful in plants having resin ducts, including 
members of the genus: Pinus, Picea, Hedera, Heracleum, 
Dorema, Solidago, Citrus, Eucalyptus, Ruta, Dictamnus, 
Saururus, Typhonium, or Pseudotsuga. 
Production of Transgenic Plants Comprising a Gene or 
Multiple Genes of Interest 
Plant transformation vectors capable of delivering DNA 
(genomic DNAs, plasmid DNAs, cDNAs, or synthetic 
DNAs) can be easily designed. Various strategies can be 
employed to introduce these DNAs to produce transgenic 
plants capable of biosynthesiZing high levels of a gene 
product of interest including: 
1. Transforming individual plants With an encoding DNA 
of interest. TWo or more transgenic plants, each con 
taining one of these DNAs, can then be groWn and 
cross-pollinated so as to produce hybrid plants contain 
ing the tWo DNAs. The hybrid can then be crossed With 
the remaining transgenic plants in order to obtain a 
hybrid plant containing all DNAs of interest Within its 
genome. 
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2. Sequentially transforming plants With plasmids con 
taining each of the encoding DNAs of interest, respec 
tively. 
3. Simultaneously cotransforming plants With plasmids 
containing each of the encoding DNAs, respectively. 
4. Transforming plants With a single plasmid containing 
tWo or more encoding DNAs of interest. 
5. Transforming plants by a combination of any of the 
foregoing techniques in order to obtain a plant that 
expresses a desired combination of encoding DNAs of 
interest. 
Traditional breeding of transformed plants produced 
according to any one of the foregoing methods by successive 
rounds of crossing can then be carried out to incorporate all 
the desired encoding DNAs in a single homoZygous plant 
line (NaWrath et al, 1994; PCT International Publication WO 
93/02187). 
In methods 2 and 3, the use of vectors containing different 
selectable marker genes to facilitate selection of plants 
containing tWo or more different-encoding DNAs is advan 
tageous. Examples of useful selectable marker genes include 
those conferring resistance to kanamycin, hygromycin, 
sulphonamides, glyphosate, bialaphos, and phosphinothri 
cm. 
Stability of Transgene Expression 
As several overexpressed enZymes may be required to 
produce optimal levels, the phenomenon of co-suppression 
may in?uence transgene expression in transformed plants. 
Several strategies can be employed to avoid this potential 
problem. 
One commonly employed approach is to select and/or 
screen for transgenic plants that contain a single intact copy 
of the transgene or other encoding DNA. Agrobacterium 
mediated transformation technologies are preferred in this 
regard. 
Inclusion of nuclear scaffold or matrix attachment regions 
(MAR) ?anking a transgene has been shoWn to increase the 
level and reduce the variability associated With transgene 
expression in plants. Flanking a transgene or other encoding 
DNA With MAR elements may overcome problems associ 
ated With differential base composition betWeen such trans 
genes or encoding DNAs and integration sites, and/or the 
detrimental effects of sequences adjacent to transgene inte 
gration sites. 
The use of enhancers from tissue-speci?c or 
developmentally-regulated genes may ensure that expres 
sion of a linked transgene or other encoding DNA occurs in 
the appropriately regulated manner. 
The use of different combinations of promoters, plastid 
targeting sequences, and selectable markers in addition to 
the trichome-speci?c regulatory sequence, for introduced 
transgenes or other encoding DNAs can avoid potential 
problems due to trans-inactivation in cases Where pyramid 
ing of different transgenes Within a single plant is desired. 
Finally, inactivation by co-suppression can be avoided by 
screening a number of independent transgenic plants to 
identify those that consistently overexpress particular intro 
duced encoding DNAs. Site-speci?c recombination in Which 
the endogenous copy of a gene is replaced by the same gene, 
but With altered expression characteristics, should obviate 
this problem. 
Any of the foregoing methods, alone or in combination, 
can be employed in order to insure the stability of transgene 
expression in transgenic plants of the present invention. 
The folloWing examples are offered by Way of illustration 
of the present invention, and not by Way of limitation. 
EXAMPLES 
Example 1 
A unique method for isolating trichome glands (glands 
from glanded leaf hairs) Was used. A novel cold brushing 
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10 
method Was used to prepare trichome glands for subtracting 
gland versus leaf-minus-gland RNA. Mature leaves (about 
40, average length 24 cm) of Nicotiana tabacum TL 1068 
Were detached and immediately froZen in the atmosphere 
above a dry ice-ethanol slush. Once froZen, these Were 
placed on a stainless steel incline, the bottom of Which Was 
submerged in a pool of liquid N2. Using a 2 inch hog-hair 
paint brush—brie?y dipped in liquid N2—leaves Were 
brushed (doWn major veins) to detach glands (some With 
stalks attached) and propel them into the liquid N2 pool. 
After ?ltering through a metal screen into a mortar to 
remove brush hair pieces, and evaporation of the liquid N2 
(to about 2 mL), 100 ml of 2-mercaptoethanol Was added 
and the preparation Was ground to a ?ne poWder, maintain 
ing liquid N2 temperature. 
Messenger RNA’s Were isolated from glands and cDNA’s 
Were prepared. A commercial subtraction kit (PCR-Select 
cDNA subtraction kit, CLONETECH LAB) Was used to 
prepare gland-speci?c cDNA’s (subtracted gland cDNA’s 
from leaf-minus-gland cDNA’s). Trichome gland unique 
cDNA’s obtained Were sequenced. One clone (1—31) 
shoWed homology to P450 genes. Northern analysis shoWed 
that this partial cDNA hybridiZed to total RNAs isolated 
from gland, but not leaf-minus-gland, ?oWer, petal, root or 
stem-minus-gland total RNA’s, indicating its gland speci 
?city. 
Genomic clones of 1—31 Were isolated using a commer 
cial tobacco genomic library. PCR based Walking Was used 
to determine the sequence and gene structure of the full 
length genomic clones. A genomic clone of 1—31 shoWs 63 
to 47% identity to the potato P450 at the amino acid and 
DNA levels, respectively. PCR based Walking Was used to 
determine the 5‘ sequence of the 1—31 gene in order to obtain 
its promoter. 
After determining 1852 base pairs, this sequence, along 
With the coding region +1 to +111, Was fused With the 
beta-glucuronidase (GUS) reporter gene, in frame, and intro 
duced into tobacco. Standard GUS staining of seedlings 
shoWed that GUS Was expressed trichome-gland 
speci?cally (FIG. 1). In FIG. 1, tissue ‘C’ is epidermis from 
leaf of a non-transformed plant, and “P-GUS” is epidermis 
from a similar aged leaf of a plant expressing the GUS 
reporter gene driven by the isolated trichome 
speci?cpromoter. Note the occurrence of GUS stain in 
glands only. Some slight blue color Was also found in the 
stalk cell immediately attached to the gland. This may 
represent leakage of stain during tissue ?xation, or move 
ment betWeen the gland and the ?rst stalk cell Within the 
vacuolar-tubularcontinuum. No stain Was found in root, 
stem, or any other tissue (not shoWn). 
Example 2 
We tested the speci?city of GUS expression in mature 
plants to be sure there is no non-gland expression in, e.g., 
mature roots. The promoter-GUS construct Was introduced 
into petunia, tomato and geranium to test the functionality of 
the promoter in these non-tobacco, glanded trichome 
bearing plants. 
Example 3 
We transformed tobacco plants With the 1—31 cDNA in 
antisense orientation. A plant Was found that had altered 
trichome exudate chemistry consistent With a partial knock 
out of a P450 function. This con?rmed the identity of the 
1—31 gene. Further, the antisense plant had enhanced insect 
resistance that is consistent With its altered exudate chem 
istry. 
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Example 4 
Adeletion analysis (promoter dissection) of the upstream 
region of an isolated trichome speci?c gene sequence to 
12 
Utility 
The DNA of the present invention has various potential 
uses. 
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(MUG) substrate. Results are shoWn in FIG. 3. Activities Those Sklned 1n the art W111 TeCOgmZe, or be able to 
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SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOs: 3 
<210> SEQ ID NO 1 
<2ll> LENGTH: 1963 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Nicotiana tabacum 
<220> FEATURE: 
<22l> NAME/KEY: exon 
<222> LOCATION: (l853)..(l963) 
<22l> NAME/KEY: CAATLsignal 
<222> LOCATION: (l669)..(l672) 
<22l> NAME/KEY: TATALsignal 
<222> LOCATION: (l775)..(l778) 
<22l> NAME/KEY: GCisignal 
<222> LOCATION: (l806)..(l807) 
<22l> NAME/KEY: promoter 
<222> LOCATION: (l)..(l852) 
<400> SEQUENCE: 1 
taagttgata aagctaattt Ctcattttag Ctaccatcgc tagtaatcgt ggcaataact 60 
accctaacta tagcatttat tgctaccaaa taaaatttgg Cagctaatca taattttttg 120 
tcatgaatca atagttattg tagcaatagt tatctcttag Ccacaataaa ttatttaaaa 180 
taaaatatta tagctaaata aatatttttg Ctttaagttc taaaaggttg tggcaatagt 240 
taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt 300 
tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt 360 
tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc 420 
aatataggtt aaattagcca Catgtttctt gctttaatag aattttgtag Ctaatcatta 480 
acttttacca Cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga 540 
tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca 600 
13 
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-oontinued 
atagtcatta Cgataaaatg atataaccac gaatatattg Caacgataaa ttctgtaact 660 
aatcattagt ttttgcgacg aggtaaattt tCCgtCaCag tagcaatctt Ctaggcacat 720 
taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa 780 
taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt 840 
taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg Caataatagt 900 
attttaacca Caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg 960 
agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag 1020 
ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa 1080 
aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct 1140 
aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt 1200 
tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga 1260 
atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt 1320 
atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt 1380 
gtCattCCtC tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt 1440 
tatttaactg tttatttCCC ttgttaatat aattggtaag aagttttaaa ataaaggagt 1500 
taatgatttt Ctaggttcat ggcttgccta gcttctacga gtaagcgcca tCaCgaCtCC 1560 
Cgaggataag gaaatccggg tcgtagcatt CaCtCaCaaa aattactaaa aacaaagttt 1620 
aCCCttCtCC Caaaagtaaa tttcatattt ggCtCCaCat aatgtgttca atgagtcaag 1680 
tgaagtactt ttcatgacaa aaaaaagttg Ctgaaaaatg Catatctcat attttttttt 1740 
tagagaaatc CCatttCttg cctaaacgaa agcctataaa agagcatata ttgcaacaac 1800 
agtttgcaga aactatcaag tcaaataatc CCCCCtttaa ttCCCtCCca aa atg Cag 1858 
Met Gln 
1 
ttc ttc aac ttc ttt tCC ctt ttc ctt ttt gtg tCa ttt ctC ttt tta 1906 
Phe Phe Asn Phe Phe Ser Leu Phe Leu Phe Val Ser Phe Leu Phe Leu 
5 10 15 
ttt aag aaa tgg aag aat tCC aat ago Caa aCC aaa aga ttg CCt CCa 1954 
Phe Lys Lys Trp Lys Asn Ser Asn Ser Gln Thr Lys Arg Leu Pro Pro 
20 25 30 
ggt CCa tgg 1963 
Gly Pro Trp 
35 
<2 10> SEQ ID NO 2 
<211> LENGTH: 1852 
<212> TYPE: DNA 
<213> ORGANISM: Nicotiana tabacum 
<220> FEATURE: 
<221> NAME/KEY: promoter 
<222> LOCATION: ( 1) . . (1852) 
<221> NAME/KEY: CAATisignal 
<222> LOCATION: ( 1669 ) . . ( 1672) 
<221> NAME/KEY: GCisignal 
<222> LOCATION: ( 1806 ) . . ( 1807) 
<400> SEQUENCE: 2 
taagttgata aagctaattt Ctcattttag CtaCCatCgC tagtaatcgt ggcaataact 60 
aCCCtaaCta tagcatttat tgctaccaaa taaaatttgg Cagctaatca taattttttg 120 
tcatgaatca atagttattg tagcaatagt tatctcttag ccacaataaa ttatttaaaa 180 
taaaatatta tagctaaata aatatttttg Ctttaagttc taaaaggttg tggcaatagt 240 
15 
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-continued 
taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt 300 
tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt 360 
tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc 420 
aatataggtt aaattagcca catgtttctt gctttaatag aattttgtag ctaatcatta 480 
acttttacca cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga 540 
tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca 600 
atagtcatta cgataaaatg atataaccac gaatatattg caacgataaa ttctgtaact 660 
aatcattagt ttttgcgacg aggtaaattt tccgtcacag tagcaatctt ctaggcacat 720 
taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa 780 
taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt 840 
taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg caataatagt 900 
attttaacca caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg 960 
agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag 1020 
ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa 1080 
aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct 1140 
aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt 1200 
tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga 1260 
atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt 1320 
atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt 1380 
gtcattcctc tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt 1440 
tatttaactg tttatttccc ttgttaatat aattggtaag aagttttaaa ataaaggagt 1500 
taatgatttt ctaggttcat ggcttgccta gcttctacga gtaagcgcca tcacgactcc 1560 
cgaggataag gaaatccggg tcgtagcatt cactcacaaa aattactaaa aacaaagttt 1620 
acccttctcc caaaagtaaa tttcatattt ggctccacat aatgtgttca atgagtcaag 1680 
tgaagtactt ttcatgacaa aaaaaagttg ctgaaaaatg catatctcat attttttttt 1740 
tagagaaatc ccatttcttg cctaaacgaa agcctataaa agagcatata ttgcaacaac 1800 
agtttgcaga aactatcaag tcaaataatc ccccctttaa ttccctccca aa 1852 
<210> SEQ ID NO 3 
<211> LENGTH: 1963 
<212> TYPE: DNA 
<213> ORGANISM: Nicotiana tabacum 
<400> SEQUENCE: 3 
taagttgata aagctaattt ctcattttag ctaccatcgc tagtaatcgt ggcaataact 60 
accctaacta tagcatttat tgctaccaaa taaaatttgg cagctaatca taattttttg 120 
tcatgaatca atagttattg tagcaatagt tatctcttag ccacaataaa ttatttaaaa 180 
taaaatatta tagctaaata aatatttttg ctttaagttc taaaaggttg tggcaatagt 240 
taaatgatat agtcacagat ttattggtat aattgaatta tgttgctaat ttcttagttt 300 
tttgccacga gttaaaaatt accaatagct atagtaactt tttaatcaca ataaaatatt 360 
tgaaagaaaa tattgtagct aaatgaatat tttttccttc aagttattaa aagttgtggc 420 
aatataggtt aaattagcca catgtttctt gctttaatag aattttgtag ctaatcatta 480 
acttttacca cgagttgaac ttaatataac aacaataacc ttttaaccat aataaagcga 540 
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tttaaatcaa atattactaa ataaataact ttgctttcaa gtttctataa aatcatggca 600 
atagtcatta cgataaaatg atataaccac gaatatattg caacgataaa ttctgtaact 660 
aatcattagt ttttgcgacg aggtaaattt tccgtcacag tagcaatctt ctaggcacat 720 
taaaaatttg aaacaaaatt ttgtagtcaa ataaatattt atcttcttat tttaagaaaa 780 
taaaaatagt tagataatag ttactactat ttgtcatgaa aatatcaata gatacaaatt 840 
taaagtgact ataaatttac gagtttacta tactttagtc gtacagtttg caataatagt 900 
attttaacca caattagtta tatgtacaaa ataacataag tgaataactt tttttcaatg 960 
agaaaataag agttgctcaa acaatatcaa gttacaaaaa tttaatttta actgtaaaag 1020 
ttatattttt ccaaaataac ataaactata gtaattatat atagtttgaa gtattaataa 1080 
aatttaaata tgcaaaagtt aattttaata aaccatttgt atgcctaact tgtagcctct 1140 
aaactatttt atttgcttta tttatcaaac tcatatttta ttttattgca ccttgttagt 1200 
tttggacgtt aattatatat atttggtgta aaatttaaaa tatattaaca tttgtggaga 1260 
atttatgtat gcctggttct taactatttt tttttatata actggttaga gtaatttctt 1320 
atatttcagt atttattttt aaataagtcc tcataaattg aagactttaa aagtttttgt 1380 
gtcattcctc tttttattta agaaattgaa gaattccgct aaatttcata tttccgctgt 1440 
tatttaactg tttatttccc ttgttaatat aattggtaag aagttttaaa ataaaggagt 1500 
taatgatttt ctaggttcat ggcttgccta gcttctacga gtaagcgcca tcacgactcc 1560 
cgaggataag gaaatccggg tcgtagcatt cactcacaaa aattactaaa aacaaagttt 1620 
acccttctcc caaaagtaaa tttcatattt ggctccacat aatgtgttca atgagtcaag 1680 
tgaagtactt ttcatgacaa aaaaaagttg ctgaaaaatg catatctcat attttttttt 1740 
tagagaaatc ccatttcttg cctaaacgaa agcctataaa agagcatata ttgcaacaac 1800 
agtttgcaga aactatcaag tcaaataatc ccccctttaa ttccctccca aaatgcagtt 1860 
cttcaacttc ttttcccttt tcctttttgt gtcatttctc tttttattta agaaatggaa 1920 
gaattccaat agccaaacca aaagattgcc tccaggtcca tgg 1963 
What is claimed is: 
1. An isolated nucleic acid molecule comprising: 
the polynucleotide sequence set forth in SEQ ID NO: 1; 
or 
a fragment of the polynucleotide sequence set forth in 
SEQ ID NO: 1 comprising bases 578—1963 of SEQ ID 50 
NO: 1, Wherein SEQ ID NO: 1 and said fragment have 
plant trichome gland speci?c transcriptional activity. 
2. The nucleic acid molecule of claim 1, Which comprises 
said fragment. 
3. The nucleic acid molecule of claim 1, further compris 
ing a polynucleotide sequence encoding a polypeptide. 
4. The nucleic acid molecule according to claim 3, 
Wherein said polypeptide is a disease- or pest-resistance 
conferring protein. 
5. The nucleic acid molecule according to claim 3, 
Wherein said polypeptide is a pharmaceutical compound. 
6. The nucleic acid molecule according to claim 3, 
Wherein said polypeptide is a phytotoXic protein. 
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7. A vector, comprising: 
the isolated nucleic acid molecule of claim 1. 
8. The vector of claim 7, Which is an eXpression vector. 
9. The vector of claim 7, Which is a plant vector. 
10. A host cell containing the vector of claim 7. 
11. The host cell of claim 10, Which is a plant cell. 
12. A transgenic plant comprising the nucleic acid mol 
ecule of claim 1. 
13. A transgenic seed comprising the nucleic acid mol 
ecule of claim 1. 
14. A method for eXpressing a polypeptide comprising: 
constructing a vector comprising the isolated nucleic acid 
molecule of claim 1 operably linked to a nucleic acid 
encoding a polypeptide; and 
inserting said vector into a plant, Wherein said polypep 
tide is expressed trichome gland speci?cally. 
15. The transgenic plant of claim 12, Wherein the trans 
genic plant is a food plant or horticultural plant. 
